Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Erectile dysfunction Stories

2011-11-03 06:00:00

MALVERN, Pa., Nov. 3, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced the release of clinical practice data from the Testim Registry in the United States (TRiUS). This study showed that daily administration of Testim® 1% (testosterone gel) resulted in significantly improved sexual function and increased total testosterone levels in men with hypogonadism, often referred to as low testosterone. Sexual function assessments from TRiUS, which...

2011-11-03 05:45:00

MOUNTAIN VIEW, Calif., Nov. 3, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Credit Suisse 2011 Healthcare Conference. The VIVUS presentation will take place at the Arizona Biltmore Hotel in Phoenix, AZ on Thursday, November 10, 2011 at 9:30 a.m. MST. A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com. About...

2011-10-28 07:00:00

Advanced Male Medical Center, a medical clinic devoted to the needs of men facing Erectile Dysfunction and Premature Ejaculation, is now offering the HCG diet. San Francisco, CA (PRWEB) October 28, 2011 Advanced Male Medical Center, a San Francisco medical clinic devoted to the needs of men facing erectile dysfunction and premature ejaculation, is now offering the HCG diet. Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone produced in the early stages of pregnancy. This material...

2011-10-21 06:55:00

PARSIPPANY, N.J., Oct. 21, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that the U.S. Food and Drug Administration (FDA) approved its Androderm® (testosterone transdermal system) 2 mg and 4 mg formulation. The new smaller size and lower-dose testosterone patch provides highly effective testosterone administration with a 20 percent reduction in the active ingredient from the original strength in a smaller patch size. Watson plans to...

2011-10-20 07:00:00

Renown urologist, Peter Sinaiko, MD FACS, launches new blog to educate patients, medical professionals and regulators about the efficacy of HIFU therapy for treatment of prostate cancer. The blog is located at http://www.hifuprostatecancerdoctor.com. Langhorne, PA (PRWEB) October 20, 2011 Sinako Urology, led by Peter Sinako, MD FACS, announced that it has launched a website and blog dedicated to the coverage of High Intensity Focused Ultrasound or HIFU for the treatment of prostate cancer...

2011-10-19 08:14:49

Men's experiences of erectile dysfunction after treatment for colorectal cancer: Qualitative interview study Male bowel cancer patients are very likely to suffer from erectile dysfunction (ED) after treatment and yet the majority are not receiving adequate information about the condition, according to a study published on bmj.com today. Bowel cancer affects over 38,000 people every year in the UK with around half of patients surviving for more than five years after treatment. This...

2011-10-14 05:45:00

MOUNTAIN VIEW, Calif., Oct. 14, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the 2011 BioCentury NewsMakers in the Biotech Industry Conference. The VIVUS presentation will take place at the Millennium Broadway Hotel in New York, NY on Friday, October 21, 2011 at 10:00 a.m. ET. A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com. About...

2011-10-12 10:00:00

Do you need a PSA test? Blue pills, yellow pills, white pills, or the new âœbreath mintsââ”which is right for E.D.? How can you have an amazing, satisfying sex life? In his latest book, renowned board-certified urologist Dudley Danoff, MD provides the answers to these and many more questions about menâs sexual health. Los Angeles, CA (PRWEB) October 12, 2011 In his latest book, Penis Power: The Ultimate Guide to Male...

2011-10-12 07:00:00

INDIANAPOLIS, Oct. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a pivotal Phase III study of Cialis® (tadalafil) tablets 5 mg for once daily use met its co-primary endpoints, significantly improving measures of both erectile dysfunction (ED) and signs and symptoms of benign prostatic hyperplasia (BPH) in men with both conditions. The study is available online in The Journal of Sexual Medicine. It is one of three efficacy and safety...

2011-10-07 07:00:00

San Francisco's Advanced Male Medical Center, in partnership with The San Francisco Examiner and the San Francisco Senior Center, is offering a free class to learn about the effects of low testosterone in men and women on October 19th. San Francisco, CA (PRWEB) October 07, 2011 Advanced Male Medical Center exclusively specializes in and is dedicated to removing the difficulties that keep men from experiencing a healthy and active sex life. As part of their program, which guarantees results,...